1. Pink Sheet

US FDA Advisory Committee Drought Is Over … Unless Sponsors Are Scared Of Dark Clouds

 
• By Michael McCaughan

FDA has three NDAs set for public advisory committee review at the end of March and early April, the first 'real' committee meetings in five months. Oops. Make that two.

On March 29, FDA will host its first new drug application focused advisory committee meeting in almost five months – assuming a sponsor is willing to go through with it.

It has been a long time since FDA last held a public advisory committee review of a pending new drug...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from US FDA Performance Tracker

More from Regulatory Trackers